Middleton & CO Inc Danaher Corp Transaction History

Middleton & CO Inc

$898 Million
Q3 2024

A detailed history of Middleton & CO Inc transactions in Danaher Corp stock. As of the latest transaction made, Middleton & CO Inc holds 83,044 shares of DHR stock, worth $19.2 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares

83,044

Previous 85,116 2.43%

Holding current value

$19.2 Million

Previous $21.3 Million 8.55%

% of portfolio

2.57%

Previous 2.48%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$239.25 - $280.76 $495,726 - $581,734	-2,072 Reduced 2.43%	83,044 $23.1 Million
Q2 2024 Aug 12, 2024	SELL	$235.51 - $267.98 $397,305 - $452,082	-1,687 Reduced 1.94%	85,116 $21.3 Million
Q1 2024 May 14, 2024	SELL	$224.58 - $256.19 $22,008 - $25,106	-98 Reduced 0.11%	86,803 $21.7 Million
Q4 2023 Feb 13, 2024	SELL	$185.1 - $233.13 $806,850 - $1.02 Million	-4,359 Reduced 4.78%	86,901 $20.1 Million
Q3 2023 Oct 26, 2023	SELL	$233.08 - $265.59 $327,244 - $372,888	-1,404 Reduced 1.52%	91,260 $22.6 Million
Q2 2023 Jul 28, 2023	BUY	$224.99 - $256.14 $3.01 Million - $3.43 Million	13,399 Added 16.9%	92,664 $22.2 Million
Q1 2023 Apr 28, 2023	BUY	$239.75 - $277.0 $124,430 - $143,763	519 Added 0.66%	79,265 $20 Million
Q4 2022 Feb 09, 2023	SELL	$241.42 - $282.29 $510,844 - $597,325	-2,116 Reduced 2.62%	78,746 $20.9 Million
Q3 2022 Nov 02, 2022	SELL	$247.06 - $1507.4 $3.58 Million - $21.8 Million	-14,478 Reduced 15.19%	80,862 $20.9 Million
Q2 2022 Jul 21, 2022	SELL	$237.11 - $299.66 $323,892 - $409,335	-1,366 Reduced 1.41%	95,340 $24.2 Million
Q1 2022 May 12, 2022	SELL	$257.27 - $315.76 $130,950 - $160,721	-509 Reduced 0.52%	96,706 $28.4 Million
Q4 2021 Feb 09, 2022	SELL	$292.08 - $329.01 $382,624 - $431,003	-1,310 Reduced 1.33%	97,215 $32 Million
Q3 2021 Nov 08, 2021	SELL	$272.21 - $332.43 $554,219 - $676,827	-2,036 Reduced 2.02%	98,525 $30 Million
Q2 2021 Aug 13, 2021	SELL	$225.08 - $271.69 $2.17 Million - $2.61 Million	-9,620 Reduced 8.73%	100,561 $27 Million
Q1 2021 May 06, 2021	SELL	$212.38 - $245.9 $642,237 - $743,601	-3,024 Reduced 2.66%	110,538 $28.1 Million
Q1 2021 May 06, 2021	SELL	$212.38 - $245.9 $75,819 - $87,786	-357 Reduced 0.32%	110,181 $24.8 Million
Q4 2020 Jan 29, 2021	SELL	$212.5 - $245.46 $880,175 - $1.02 Million	-4,142 Reduced 3.52%	113,562 $25.2 Million
Q3 2020 Oct 30, 2020	SELL	$177.16 - $215.33 $429,081 - $521,529	-2,422 Reduced 2.02%	117,704 $25.3 Million
Q2 2020 Jul 28, 2020	SELL	$128.7 - $176.83 $184,813 - $253,927	-1,436 Reduced 1.18%	120,126 $21.2 Million
Q1 2020 Apr 22, 2020	SELL	$121.39 - $169.05 $832,249 - $1.16 Million	-6,856 Reduced 5.34%	121,562 $16.8 Million
Q4 2019 Jan 29, 2020	SELL	$133.47 - $153.48 $271,477 - $312,178	-2,034 Reduced 1.56%	128,418 $19.7 Million
Q3 2019 Oct 21, 2019	SELL	$135.4 - $146.47 $1.19 Million - $1.28 Million	-8,764 Reduced 6.3%	130,452 $18.8 Million
Q2 2019 Jul 25, 2019	SELL	$124.88 - $143.73 $712,440 - $819,979	-5,705 Reduced 3.94%	139,216 $19.9 Million
Q1 2019 Apr 25, 2019	SELL	$97.62 - $132.29 $225,502 - $305,589	-2,310 Reduced 1.57%	144,921 $19.1 Million
Q4 2018 Feb 01, 2019	SELL	$94.85 - $109.54 $464,006 - $535,869	-4,892 Reduced 3.22%	147,231 $15.2 Million
Q3 2018 Oct 25, 2018	BUY	$98.13 - $108.9 $242,381 - $268,983	2,470 Added 1.65%	152,123 $16.5 Million
Q2 2018 Jul 26, 2018	SELL	$96.1 - $103.24 $194,794 - $209,267	-2,027 Reduced 1.34%	149,653 $14.8 Million
Q1 2018 May 04, 2018	SELL	$92.16 - $103.8 $969,523 - $1.09 Million	-10,520 Reduced 6.49%	151,680 $14.9 Million
Q4 2017 Jan 25, 2018	BUY	$85.26 - $94.62 $192,346 - $213,462	2,256 Added 1.41%	162,200 $15.1 Million
Q3 2017 Oct 31, 2017	BUY	$79.29 - $88.45 $12.7 Million - $14.1 Million	159,944	159,944 $13.7 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.

Account